In last trading session, Solid Biosciences Inc (NASDAQ:SLDB) saw 1.03 million shares changing hands with its beta currently measuring 1.88. Company’s recent per share price level of $5.14 trading at -$0.59 or -10.21% at ring of the bell on the day assigns it a market valuation of $398.70M. That closing price of SLDB’s stock is at a discount of -192.8% from its 52-week high price of $15.05 and is indicating a premium of 43.97% from its 52-week low price of $2.88. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.27 million shares which gives us an average trading volume of 2.34 million if we extend that period to 3-months.
For Solid Biosciences Inc (SLDB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.08. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.54 in the current quarter.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Upright in the red during last session for losing -10.21%, in the last five days SLDB remained trading in the red while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $5.14 price level, adding 12.14% to its value on the day. Solid Biosciences Inc’s shares saw a change of 28.62% in year-to-date performance and have moved -6.45% in past 5-day. Solid Biosciences Inc (NASDAQ:SLDB) showed a performance of 55.91% in past 30-days. Number of shares sold short was 7.32 million shares which calculate 1.5 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 19 to the stock, which implies a rise of 72.95% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would drop -133.46% in reaching the projected high whereas dropping to the targeted low would mean a loss of -133.46% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 41.25% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 28.30% while estimates for its earnings growth in next 5 years are of 9.81%.
Solid Biosciences Inc (NASDAQ:SLDB)’s Major holders
Insiders are in possession of 0.45% of company’s total shares while institution are holding 62.23 percent of that, with stock having share float percentage of 62.51%. Investors also watch the number of corporate investors in a company very closely, which is 62.23% institutions for Solid Biosciences Inc that are currently holding shares of the company.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 854.68 shares of worth $4.4 million or 1.10% of the total outstanding shares. The later fund manager was in possession of 628.9 shares on Dec 31, 2024 , making its stake of worth around $3.24 million in the company or a holder of 0.81% of company’s stock.
